S6K-17438-94436
3 vaccinations
1 coded response
28 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 132 / NY
- Registered
- 2021-12-01
- Relationship
- Child or adolescent in my care
- Guardian
- AFN-13005-65353
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-11
Dose 1 — Pfizer-BioNTech
-
2021-12-01
Registered in v-safe
- 2021-12-01
- 2021-12-02
-
2021-12-04
Dose 2 — Pfizer-BioNTech
-
2021-12-06
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-19
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-01-15
- 2022-03-05
-
2022-05-28
Dose 3 — Pfizer-BioNTech
- 2022-05-28
-
2022-05-29
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · NoneAdult check-in
-
2022-05-30
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-06-01
- 2022-06-02
- 2022-06-04
- 2022-06-12
- 2022-06-18
- 2022-06-27
- 2022-07-04
- 2022-07-09
- 2022-08-27
-
2022-11-26
Survey response — 6 months, dose 3, dependentMedDRA: Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Viral illnessesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-26
Report sent to call center — 6 months, dose 3, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-05-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-11 | Pfizer-BioNTech | No |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
| 3 | 2022-05-28 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 6 months, dose 3, dependent
Symptoms: Viral illnesses
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release